| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.32 | 0.03 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.13 | 0.03 |